Exhibit 99.5
FORM 51-102F3
SECURITIES ACT
MATERIAL CHANGE REPORT
Item 1Name and address of Company
Avricore Health Inc.
2300-1177 West Hastings Street
Vancouver BC V6E 2K3
Item 2Date of Material Change
July 6, 2020
Item 3Press Release
News Release, dated July 6, 2020, disseminated via Globenewswire under section 7.1 of National Instrument 51-102
Item 4Summary of Material Change
See attached copy of the July 6, 2020 news release.
Item 5Full Description of Material Change
See attached copy of the July 6, 2020 news release.
Item 6Reliance on subsection 7.1(2) or (3) of National Instrument 51-102:
Not applicable.
Item 7 Omitted Information
Not applicable.
Item 8Senior Officers
Hector Bremner, CEO of the Issuer, is knowledgeable about the material change and this report. His business telephone number is (604) 773-8943
Item 9Date of Report
July 6, 2020
“Hector Bremner”
___________________
Hector D. Bremner, CEO
Director
AVRICORE HEALTH AMENDS SHARES FOR DEBT NEWS RELEASE
VANCOUVER, BRITISH COLUMBIA – July 6, 2020) – AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) wishes to amend its news release dated July 2,2020 in which it announced a shares for debt transaction.
Aggregate shares has been amended from 5,077,965 to 5,477,965 shares.
Contact:
Hector Bremner, CEO 604-773-8943
info@avricorehealth.com
www.avricorehealth.com
About Avricore Health Inc.
Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company's goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health. www.avricorehealth.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.